Literature DB >> 31661359

Recognizing Persistent Disease in Well-Differentiated Thyroid Cancer and Association with Lymph Node Yield and Ratio.

Julia E Noel1, Lisa A Orloff1.   

Abstract

OBJECTIVE: To establish the association between lymph node yield and ratio in neck dissection for well-differentiated thyroid cancer and risk for persistent postoperative disease. STUDY
DESIGN: Retrospective cohort study of patients undergoing lymphadenectomy for thyroid carcinoma.
SETTING: Tertiary referral center. SUBJECTS AND METHODS: Included patients underwent central and/or lateral neck dissection for papillary thyroid carcinoma at our institution between 1994 and 2015. They were divided into a persistent disease group with biochemical and structural disease (49 patients) and a disease-free group with no disease after a minimum 2 years of follow-up (175 patients). Demographic characteristics, adjuvant therapy, tumor, and lymph node features were compared.
RESULTS: There were no significant differences in demographic characteristics between the groups. The mean nodal yield of patients with central and lateral neck persistence was significantly lower than that of patients remaining disease free (4.8 vs. 11.9: odds ratio [OR] 0.69; 95% CI, 0.59 to 0.8; P < .001; 14.8 vs. 31.0: OR, 0.89; 95% CI, 0.84-0.94; P < .001, respectively). Nodal ratio was higher in patients with persistence in the central and lateral neck (74.2% vs 29.4%: OR, 1.06; 95% CI, 1.04-1.08; P < .001; 54.2% vs 19.8%: OR, 1.08; 95% CI, 1.04-1.12; P < .001, respectively).
CONCLUSIONS: Lower lymph node yield and higher node ratio from cervical lymph node dissections are associated with persistent disease and have potential applications in surgical adequacy.

Entities:  

Keywords:  lymph node ratio; lymph node yield; neck dissection; persistent thyroid cancer; surgical quality; thyroid cancer

Mesh:

Year:  2019        PMID: 31661359     DOI: 10.1177/0194599819886123

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  3 in total

1. 

Authors:  文 刘; 治中 董; 艳军 苏; 云海 马; 建明 张; 畅 刁; 军 钱; 若川 程
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

2.  Risk probability model for residual metastatic lymph node in patients with papillary thyroid microcarcinoma undergoing cervical central lymph node dissection.

Authors:  Wen Liu; Zhizhong Dong; Yanjun Su; Yunhai Ma; Jianming Zhang; Chang Diao; Jun Qian; Ruochuan Cheng
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

3.  Mitoxantrone hydrochloride injection for tracing helps to decrease parathyroid gland resection and increase lymph node yield in thyroid cancer surgery: a randomized clinical trial.

Authors:  Shaobo Chen; Xianming Hou; Surong Hua; Ziwen Liu; Binglu Li; Xiaoyi Li; Lin Cong; Quan Liao; Jugao Fang; Lizhen Hou; Shanghua Jing; Zhen Zhao; Jianwu Qin; Songtao Zhang; Zhendong Li; Dongning Huang; Ning Zhang; Yongfu Zhao; Jun Liu; Shujun Wang; Ge Chen; Yupei Zhao
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.